Role of Epidermal Growth Factor Receptor (EGFR) Inhibitors and Radiation in the Management of Brain Metastases from EGFR Mutant Lung Cancers

Eitemau Tebyg

• Diffuse Lung Metastases in EGFR-Mutant Non-Small Cell Lung Cancer
  gan: Digumarthy, Subba R., et al.
  Cyhoeddwyd: (2019)
• Integration of Stereotactic Body Radiation Therapy With Tyrosine Kinase Inhibitors in Stage IV Oncogene-Driven Lung Cancer
  gan: Campo, Meghan, et al.
  Cyhoeddwyd: (2016)
• Cranial Irradiation for Patients with Epidermal Growth Factor Receptor (EGFR) Mutant Lung Cancer Who Have Brain Metastases in the Era of a New Generation of EGFR Inhibitors
  gan: Lee, Jih‐Hsiang, et al.
  Cyhoeddwyd: (2019)
• Safety and Success of Repeat Lung Needle Biopsies in Patients with Epidermal Growth Factor Receptor‐Mutant Lung Cancer
  gan: Fintelmann, Florian J., et al.
  Cyhoeddwyd: (2019)
• Acquired Resistance of EGFR-Mutated Lung Cancer to Tyrosine Kinase Inhibitor Treatment Promotes PARP Inhibitor Sensitivity
  gan: Marcar, Lynnette, et al.
  Cyhoeddwyd: (2019)